Development
Ultralife Corporation
ULBI
$7.78
$0.0851.11%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 4.10M | 2.53M | -297.00K | -119.00K | -1.03M |
| Total Depreciation and Amortization | 3.99M | 4.13M | 4.29M | 4.46M | 4.34M |
| Total Amortization of Deferred Charges | 59.00K | 51.00K | 45.00K | 36.00K | 51.00K |
| Total Other Non-Cash Items | 1.61M | 1.01M | -221.00K | -187.00K | -243.00K |
| Change in Net Operating Assets | -7.69M | -5.20M | -3.22M | -5.45M | -11.09M |
| Cash from Operations | 2.06M | 2.52M | 594.00K | -1.26M | -7.96M |
| Capital Expenditure | -1.83M | -2.11M | -1.81M | -1.68M | -1.89M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -23.52M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.83M | -2.11M | -1.81M | -1.68M | -25.41M |
| Total Debt Issued | 6.25M | 6.10M | 4.20M | 3.35M | 24.33M |
| Total Debt Repaid | -3.00M | -3.00M | -3.00M | -2.83M | -1.62M |
| Issuance of Common Stock | 1.04M | 65.00K | 3.00K | 116.00K | 116.00K |
| Repurchase of Common Stock | -4.00K | -4.00K | -8.00K | -15.00K | -11.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.00K | -75.00K | -100.00K | -100.00K | -139.00K |
| Cash from Financing | 4.21M | 3.09M | 1.10M | 518.00K | 22.68M |
| Foreign Exchange rate Adjustments | -193.00K | -333.00K | -329.00K | -276.00K | -108.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.25M | 3.17M | -445.00K | -2.70M | -10.80M |